GGrantIndex
Sort

51,593 grants matching hepatitis

Project 1. Diabetes, triglyceride-rich lipoproteins, and advanced atherosclerosis

$387,419
Karin E. Bornfeldt · University Of Washington · P01 · FY2021 · HL

Role of the RB tumor suppressor in liver tumorigenesis

$387,406
Erik Knudsen · University Of Arizona · R01 · FY2017 · CA

Structural Dynamics of Viral Proteins: Computational Investigation of Capsids, Lytic Peptides and Nucleoproteins Under Varying Conditions

$387,360
Eric Robert May · University Of Connecticut Storrs · R35 · FY2017 · GM

Epigenetic Regulation of HBV cccDNA Transcription

$387,357
Haitao Guo · University Of Pittsburgh At Pittsburgh · R01 · FY2022 · AI

Epigenetic Control of SMC Transitions to a Multi-Potential Stem Cell-Like State

$387,320
Gary K Owens · University Of Virginia · R01 · FY2013 · HL

Structure and function of the HCV RNA replicase

$387,294
Charles M. Rice · Rockefeller University · R01 · FY2009 · CA

Discovery of chemically validated malaria liver stage targets

$387,292
Elizabeth A Winzeler · University Of California, San Diego · R01 · FY2012 · AI

Neuroendocrine Regulation of Adipocyte Metabolism

$387,256
Matthias H Tschop · University Of Cincinnati · R01 · FY2009 · DK

Epigenetic Regulation of HBV cccDNA Transcription

$387,255
Haitao Guo · University Of Pittsburgh At Pittsburgh · R01 · FY2024 · AI

Molecular Mechanisms of HBV cccDNA Formation

$387,255
Haitao Guo · University Of Pittsburgh At Pittsburgh · R01 · FY2025 · AI

Effects of beta-carotene on vitamin A production in atherosclerosis and obesity

$387,203
Jaime Amengual Terrasa · University Of Illinois At Urbana-Champaign · R01 · FY2020 · HL

Mechanisms of alcohol and menthol dependent pharmaco-neurological interactions with arecoline, an addictive and toxic areca (betel) nut xenobiotic

$387,189
Alan L Myers · University Of Texas Hlth Sci Ctr Houston · R01 · FY2025 · DA

Examining Epidemiology of Folate Status Attributable to Adolescent Alcohol Use

$387,181
Julie May Croff · Osu Center For Health Sciences · P20 · FY2018 · GM

Novel Anti-Diabetic Actions of Hypothalamic FGF19-FGFR1 Signaling

$387,150
Michael W Schwartz · University Of Washington · R01 · FY2017 · DK

Novel Anti-Diabetic Actions of Hypothalamic FGF19-FGFR1 Signaling

$387,150
Michael W Schwartz · University Of Washington · R01 · FY2016 · DK

Role of the Omentum in the Treatment of Morbid Obesity

$387,147
Naji N Abumrad · Vanderbilt University · R01 · FY2008 · DK

Community Outreach and Engagement

$387,140
Laura Fejerman · University Of California At Davis · P30 · FY2024 · CA

PREVENTION OF HIV AMONG NEW IDUS AND NON-IDUS IN HARLEM

$387,127
New York Academy Of Medicine · R01 · FY2004 · DA

Hepatic Tissue Engineering

$387,087
Martin L Yarmush · Massachusetts General Hospital · R01 · FY2006 · DK

Silencing of HIV-1 proviruses by epigenetically targeting transcriptional elongation

$387,083
Qin Feng · University Of Houston · R33 · FY2020 · AI

Adhesive Signaling by Platelet Integrins

$387,083
Sanford J Shattil · University Of California, San Diego · R01 · FY2012 · HL

The role of hepatic Endoplasmic Reticulum architecture in metabolic homeostasis and disease

$387,082
Ana Paula Arruda · University Of California Berkeley · R01 · FY2024 · DK

Surgery triggered immune response and liver metastases

$387,041
Allan Tsung · University Of Virginia · R01 · FY2024 · CA

QUANTIFYING THE BALANCE BETWEEN VACCINE-INDUCED T CELL PROTECTION AND PATHOLOGY

$387,000
Rustom Noshir Antia · Emory University · R01 · FY2016 · AI

Genetic determinants of ACEI prodrug activation

$387,000
Haojie Zhu · University Of Michigan At Ann Arbor · R01 · FY2017 · HL